EuroFlow logo
banner

EuroFlow develops and standardizes fast, accurate, and highly sensitive flow cytometric tests for diagnosis and prognostic (sub)classification of hematological malignancies as well as for evaluation of treatment effectiveness during follow-up. In addition to innovation, EuroFlow offers a number of services to improve the quality of diagnostics in the field of hemato-oncology worldwide, including Educational workshops, development of educational materials, organization of QA rounds and distribution of standardized protocols.

The EuroFlow Consortium consists of 19 diagnostic research groups, which are regarded as experts in the fields of flow cytometric and molecular diagnostics. Together these groups have sufficient complementarity and congruence to cover all aspects of innovation, standardization, and validation of highly sensitive flow cytometric tests for diagnosis and follow-up.

News

Excellent ESLHO week in Lisbon
Excellent ESLHO week in Lisbon
November 13, 2024

We are looking back on a wonderful ESLHO week in Lisbon, Portugal. All three ESLHO consortia EuroFlow, EuroClonality and EuroMRD had their general meetings. They were all very productive and there was also time to meet sociable during dinners which is so important to keep our cooperative work at the highest level. Highlight wasthe 13th ESLHO Symposium on Thursday. The historical Convento de Beato formed an almost magical background to host the symposium titled Muli-omics approaches for diagnosis and monitoring of hematological malignancies. The excellent invited speakers, the abstract-based selected speakers and the blitz- and poster presentations made it into a varied and scientifically highly interesting gathering. This open symposium was made possible by sponsors, who presented themselves in the well-visited sponsor area.

ESLHO, together with the independent scientific foundations EuroFlow, EuroClonality and EuroMRD, is an official EHA Specialized Working Group (SWG).

EHA-SWG logo